Vasopressor use in adult patients

Cardiology in Review

Volumn 20, Issue 3, 2012, Pages 153-158

  Ferguson Myrthil, Nadia ^a  

^a Jack D Weiler Hospital   (United States)

Author keywords

dopamine; epinephrine; mean arterial pressure; norepinephrine; phenylephrine; sepsis; shock; vasopressin; vasopressors

Indexed keywords

ADRENALIN; DOPAMINE; HYPERTENSIVE AGENT; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN;

ABDOMINAL DISTENSION; ADRENERGIC STIMULATION; ANAPHYLAXIS; ANGINA PECTORIS; ANXIETY; ASTHMA; BLEEDING; BRADYCARDIA; BRONCHOSPASM; CARDIOGENIC SHOCK; CROUP; DIABETES INSIPIDUS; DIAPHORESIS; DIZZINESS; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG URINE LEVEL; DYSPNEA; DYSURIA; ECTOPIA CORDIS; EXTRAVASATION; FEVER; FLUSHING; GANGRENE; HALLUCINATION; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEART PALPITATION; HEART RATE; HEART STIMULATION; HUMAN; HYPERTENSION; HYPOTENSION; HYPOXEMIA; INJECTION SITE EXTRAVASATION; INJECTION SITE NECROSIS; ISCHEMIA; KIDNEY DISEASE; LUNG EDEMA; METABOLIC ACIDOSIS; MYDRIASIS; NAUSEA; NAUSEA AND VOMITING; PARESTHESIA; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; POLYURIA; REVIEW; SEPTIC SHOCK; SHOCK; SIDE EFFECT; STOMACH IRRITATION; TACHYCARDIA; THORAX PAIN; TREMOR; URINE RETENTION; VERTIGO; WEAKNESS; XEROSTOMIA;

ADULT; DRUG INTERACTIONS; HUMANS; HYPOTENSION; SHOCK; VASOCONSTRICTOR AGENTS;

EID: 84859651453     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31824e2294     Document Type: Review

References (21)

1. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med. 1999;27:639.
2. Beale RJ, Hollenberg SM, Vincent JL, et al. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004;32(11 Suppl):S455-S465. (Pubitemid 39489021)
3. Levophed (norepinephrine bitartrate injection) [package insert]. Lake Forest, IL: Hospira, Inc.; 2007
4. Micromedex Healthcare Series Web site. Available at http://www.thomsonhc. com/micromedex2/librarian. Accessed December 15, 2011.
5. Dasta JF. Norepinephrine in septic shock: renewed interest in an old drug. Ann Pharmacotherapy. 1990; 24:153-156. (Pubitemid 20105798)
6. Lexi-Comp [Computer program]. Version 1.7.3(151). Hudson, OH: Lexi-Comp Inc. 2010.
7. Martin SJ, ed. The Injectable Drug Reference. Mount Prospect, IL: Society of Critical Care. 2006; 193-484.
8. Phenylephrine Hydrochloride Injection [package insert]. Deerfield, IL: Baxter; 2005.
9. Williamson AP, Seifen E, Lindemann JP, et al. WB4101- and CEC- sensitive positive inotropic actions of phenylephrine in rat cardiac muscle. Am J Physiol. 1994;266(6 Pt 2):H2462-H2467. (Pubitemid 24215881)
10. Dopamine hydrochloride [package insert]. Deerfield, IL: Baxter; 2006.
11. Bailey AR, Burchett KR. Effect of low-dose dopamine on serum concentrations of prolactin in critically-ill patients. Br J of Anaesth. 1997;78:97-99. (Pubitemid 27047424)
12. Epinephrine Injection, USP, 1:1000 [package insert]. South El Monte, CA: Amphastar Pharmaceuticals Co.; 2008.
13. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126:477-80.e1.
14. De Backer D, Creteur J, Silva E, et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med. 2003;31:1659-1667. (Pubitemid 36714218)
15. Verbalis JG. AVP receptor antagonists as aquaretics: review and assessment of clinical data. Cleve Clin J Med. 2006;73 Suppl 3:S24-S33.
16. Dellinger RP, Levy MM, Carlet JM, et al.; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
17. Sennoun N, Montemont C, Gibot S, et al. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med. 2007;35:1736-1740. (Pubitemid 46985878)
18. Rivers E, Nguyen B, Havstad S, et al.; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-1377.
19. LeDoux D, Astiz ME, Carpati CM, et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 2000;28:2729-2732.
20. De Backer D, Biston P, Devriendt J, et al.; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779-789.
21. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med. 1996;24:1580-1590.